Skip to main content
GutCited
1–28) and intervention period (day 29–56) for placebo (n=57), prebiotic acacia fiber (AF) (n=55) and probiotic Bifidobacterium Lactis (Bla80) (n=57) treatment
Figure 6. 1–28) and intervention period (day 29–56) for placebo (n=57), prebiotic acacia fiber (AF) (n=55) and probiotic Bifidobacterium Lactis (Bla80) (n=57) treatment

描述

Daily symptom data spanning the run-in period (days 1-28) and intervention period (days 29-56) for placebo, prebiotic acacia fiber, and probiotic Bifidobacterium lactis groups in the gastrointestinal complaint trial.

More Figures from This Paper

Clinical outcome data from a trial comparing acacia fiber and probiotic Bifidobacterium lactis (Bla80) supplementation for relieving gastrointestinal complaints in adult participants.

Figure 2

Clinical outcome data from a trial comparing acacia fiber and probiotic Bifidobacterium lactis (Bla80) supplementation for relieving gastrointestinal complaints in adult participants.

chart
Stool mass measurements before and after intervention with acacia fiber or probiotic Bifidobacterium lactis (Bla80) for gastrointestinal complaints, comparing changes between treatment groups.

Figure 3

Stool mass measurements before and after intervention with acacia fiber or probiotic Bifidobacterium lactis (Bla80) for gastrointestinal complaints, comparing changes between treatment groups.

chart
Stool mass measurements before and after intervention with acacia fiber or probiotic Bifidobacterium lactis (Bla80) for gastrointestinal complaints, comparing changes between treatment groups.

Figure 4

Stool mass measurements before and after intervention with acacia fiber or probiotic Bifidobacterium lactis (Bla80) for gastrointestinal complaints, comparing changes between treatment groups.

chart
Longitudinal gastrointestinal symptom tracking during the acacia fiber and probiotic Bifidobacterium lactis intervention trial, with the vertical dashed line marking the transition from baseline to active treatment.

Figure 5

Longitudinal gastrointestinal symptom tracking during the acacia fiber and probiotic Bifidobacterium lactis intervention trial, with the vertical dashed line marking the transition from baseline to active treatment.

chart

Figure 6

Chart
987 × 745px · 127.1 KB

Source Paper

Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention …

European journal of nutrition (2024)

PMID: 38653808

DOI: 10.1007/s00394-024-03398-8

Cite This Figure

![Figure 6: Daily symptom data spanning the run-in period (days 1-28) and intervention period (days 29-56) for placebo, prebiotic acacia fiber, and probiotic Bifidobacterium lactis groups in the gastrointestinal complaint trial.](https://pdfs.citedhealth.com/figures/38653808/163.png)

> Source: Lonneke JanssenDuijghuijsen et al. "Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in ." *European journal of nutrition*, 2024. PMID: [38653808](https://pubmed.ncbi.nlm.nih.gov/38653808/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/38653808/163.png" alt="Daily symptom data spanning the run-in period (days 1-28) and intervention period (days 29-56) for placebo, prebiotic acacia fiber, and probiotic Bifidobacterium lactis groups in the gastrointestinal complaint trial." />
  <figcaption>Figure 6. Daily symptom data spanning the run-in period (days 1-28) and intervention period (days 29-56) for placebo, prebiotic acacia fiber, and probiotic Bifidobacterium lactis groups in the gastrointestinal complaint trial.<br>  Source: Lonneke JanssenDuijghuijsen et al. "Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in ." <em>European journal of nutrition</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38653808/">38653808</a></figcaption>
</figure>

相关证据

B
Bifidobacterium lactis 用于 Chronic Constipation

等级 B · 4 项研究